Barbara J. Mcclure

Frome Road
Adelaide, SA 5001, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Advances in Modeling Multiple Myeloma Within the Bone Marrow Tumor Microenvironment for Exploration of Current and Emerging Therapies.

Advances in Modeling Multiple Myeloma Within the Bone Marrow Tumor Microenvironment for Exploration of Current and Emerging Therapies.

Journal: Cancers
Published: May 19, 2026

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic.

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic.

Journal: Frontiers in digital health
Published: December 19, 2025

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

Journal: British journal of haematology
Published: September 02, 2025

High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib.

High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib.

Journal: Pediatric blood & cancer
Published: August 28, 2025

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy.

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy.

Journal: Blood
Published: March 25, 2024

Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol.

Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol.

Journal: Blood neoplasia
Published: March 06, 2024

The 10th Barossa meeting: Cell Signalling to Cancer Medicine.

The 10th Barossa meeting: Cell Signalling to Cancer Medicine.

Journal: Cell death & disease
Published: January 23, 2024

Desmoglein-2 as a cancer modulator: friend or foe?

Desmoglein-2 as a cancer modulator: friend or foe?

Journal: Frontiers in oncology
Published: October 25, 2023

Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.

Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.

Journal: Cancers
Published: September 15, 2023

Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia.

Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia.

Journal: Genes
Published: December 13, 2022

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).

Journal: PLoS genetics
Published: June 21, 2022

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.

Journal: Frontiers in cell and developmental biology
Published: May 12, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026